
Aarey Drugs & Pharma Announces 36th AGM on Sep 30, 2026
Aarey Drugs & Pharmaceuticals Ltd has announced its 36th Annual General Meeting (AGM) for the financial year 2025-26. The AGM is scheduled to be held on Wednesday, September 30, 2026, at 03:00 PM through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company will also circulate its Integrated Annual Report for FY 2025-26 to shareholders electronically. Key agenda items include the adoption of the audited financial statements for the year ended March 31, 2026, and the re-appointment of Mrs. Bina Ghatalia as a Director. The notice also details the e-voting period, which starts on September 27, 2026, at 09:00 AM and ends on September 29, 2026, at 05:00 PM, with a cut-off date of September 23, 2026, for e-voting eligibility.
Key Highlights
- 36th AGM scheduled for September 30, 2026, via VC/OAVM.
- Annual Report for FY 2025-26 to be shared electronically.
- Key agenda: Adoption of FY26 audited financials.
- Director re-appointment is also on the agenda.
- E-voting window: September 27-29, 2026.
Price Impact
More from AAREYDRUGS